JACQUELINE ALBRIKES: Open Payments
NPI 1811051857 · JOHNSTON, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,204 in 145 payments from 14 companies in 2025. Trend: 2023 $2,094 · 2024 $2,424 · 2025 $3,204
Food & beverage: $3,110Education: $95
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $919 |
| Janssen Biotech, Inc. | 40 | $757 |
| Novartis Pharmaceuticals Corporation | 15 | $345 |
| Lilly USA, LLC | 7 | $254 |
| LEO Pharma Inc. | 8 | $215 |
| UCB, Inc. | 9 | $198 |
| Arcutis Biotherapeutics, Inc. | 13 | $162 |
| PFIZER INC. | 11 | $158 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $67 |
| Galderma Laboratories, L.P. | 2 | $35 |
Products named: TREMFYA, SKYRIZI, RINVOQ, Bimzelx, ADBRY, COSENTYX, Zoryve, CIBINQO.
Industry payments across RI — which companies pay providers there.
